SCHEMBL2910066

SCHEMBL2910066

Nc1nc(NCCCn2cc(C(=O)NC3CCCC(N)C3)c(-c3ccc(-n4ccnc4)cc3)c2)ccc1[N+](=O)[O-]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.38
GSK3B P49841 2/20 0.38
CDK1 P06493 1/20 0.38
CD38 P28907 6/20 0.34
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
CYP19A1 P11511 1/20 0.31
PBK Q96KB5 1/20 0.31
AXL P30530 1/20 0.31
FLT3 P36888 1/20 0.31
TYRO3 Q06418 1/20 0.31
MERTK Q12866 1/20 0.31
GAS6 Q14393 1/20 0.31
CSF1R P07333 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913331 0.92 CDK1 (0.41) GSK3AGSK3BCDK1CD38ALDH1A1
SCHEMBL2903761 0.86 CDK1 (0.38) GSK3AGSK3BCDK1CD38ALDH1A1
SCHEMBL2909762 0.86 CDK1 (0.38) GSK3AGSK3BCDK1CD38ALDH1A1
SCHEMBL2911937 0.85 CDK1 (0.42) GSK3AGSK3BCDK1ALDH1A1MAPT
SCHEMBL2909662 0.85 GSK3A (0.44) GSK3AGSK3BCDK1ALDH1A1MAPT
SCHEMBL2904020 0.83 CDK1 (0.41) GSK3AGSK3BCDK1ALDH1A1MAPT
SCHEMBL2903846 0.83 GSK3A (0.41) GSK3AGSK3BCDK1ALDH1A1MAPT
SCHEMBL2904160 0.83 GSK3A (0.41) GSK3AGSK3BCDK1ALDH1A1MAPT
SCHEMBL2909976 0.83 GSK3A (0.39) GSK3AGSK3BCDK1ALDH1A1MAPT
SCHEMBL2904171 0.82 GSK3A (0.38) GSK3AGSK3BCDK1CD38ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed